{
  "id": "tenpoint-raises-235m-as-fda-approves-presbyopia-eye-drops",
  "title": "Tenpoint raises $235m as FDA approves presbyopia eye drops",
  "summary": "Funding to support commercial launch and continued development of treatments designed to ‘rejuvenate vision in the aging eye.’ British-American biotech Tenpoint Therapeutics has raised $235 million in new financing and announced the FDA approval of its once-daily prescription eye drop for presbyopia, a common form of age-related vision loss. The funding, which combines $85 million […] The post Tenpoint raises $235m as FDA approves presbyopia eye drops appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/tenpoint-raises-235m-as-fda-approves-presbyopia-eye-drops/",
  "source": "Longevity.Technology",
  "author": "Danny Sullivan",
  "category": "news",
  "publishedAt": "2026-01-29T18:10:16.000Z",
  "fetchedAt": "2026-02-04T10:49:05.819Z",
  "relevanceScore": 0.4,
  "matchedKeywords": [
    "longevity",
    "aging"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.868Z"
}